SH emails made an impact. At least something but shouldn't have happened in the first place.
ASX Announcement
12 December 2024
BCAL Diagnostics NATA Accreditation Clarification
BCAL Diagnostics Limited (ASX: BDX) (“BCAL” or “the Company”) refers to its announcement earlier today
that its development and clinical services laboratory in North Ryde, NSW, has received formal accreditation
from the National Association of Testing Authorities Australia (NATA).
BCAL wishes to clarify and reconfirm that now that it has NATA accreditation for the laboratory, which is a
major milestone for the Company, it is currently completing the necessary validation studies for
BREASTEST®, which remains on track to be made available to clinicians in the first quarter of 2025.
This announcement has been approved by the Executive Chair for release to the ASX.
ENDS
Add to My Watchlist
What is My Watchlist?
